Pennsylvania - Faruqi & Faruqi LLP - Page 2

In re Generic Pharmaceuticals Pricing Antitrust Litig., MDL No. 2724 (E.D. Pa.)

Direct Class Settlement Approved: Mylan Pharmaceuticals, Inc., et al. v. Warner Chilcott Public Ltd. Co., et al.

In re Lidoderm Antitrust Litig., No. 14-2521 (N.D. Cal.)

In re Aggrenox Antitrust Litig., No. 14-2516 (D. Conn.)

In re Solodyn Antitrust Litig., No. 14-10438 (D. Mass.)

In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.)

In re Niaspan Antitrust Litig., No. 13-cv-1820 (E.D. Pa.)

In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., No. 13-cv-2445 (E.D. Pa.)

In re Nexium (Esomeprazole) Antitrust Litigation, No. 1:12-md-02409-WGY (D. Mass.)

Mylan Pharmaceuticals, Inc. v. Warner Chilcott Public Limited Company, et al. No. 12-3824 (E. D. Pa.)

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

Send Us a Message

New York

685 Third Avenue 26th Floor
New York New York 10017

(877) 247-4292 / (212) 983-9330

(212) 983-9331

Los Angeles

1901 Avenue of the Stars Suite 1060
Los Angeles California 90067

(424) 256-2884

(424) 256-2885

Atlanta

3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305

(404) 847-0617

(404) 506-9534

Philadelphia

1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103

(215) 277-5770

(215) 277-5771